lucius卢修斯 吡非尼酮 Pirfenidone特发性肺纤维化

吡非尼酮

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Pirfenidone

老挝国家食药监局批准上市
老挝国家药检所检测认证

Each capsule contains

LUCiUS

Pirfenidone ......

特发性肺纤维化

Indication:

PHARMACEUTICALS

LuciPirfe is a pyridone indicated for the

.200mg

treatment of idiopathic pulmonary libros
(IPF).
Dosage and Use,
.Recommended dosage: 600 mg Ithree

LuciPirfe

capsules) three times daily taken with food.
.Upon initiation of treatment, the da
dosage should be titrated to the full dosag
of ninc capsules per dav over a 14-day

periou.

Pirfenidone Capsules
200mg

FDA批准

Storage: in a dry place and store at 20C to
25℃.
Warning:
Keep medicine out of reach of Children. Do
not administer LuciPirfe during Pregnancy

Rx Only

and Lactation.
PLEASE SEE PACKAGE INSER
Manufactured and Marketed by:

LUCÍUS

权威认证

PAARMACEUTICAUS
Thongmang village, Xaythany district,
Vientiane Capital, Laos
www.lucrus.la

warning: To be sold by retail on prescrintio
eacred physicians only, and as directed

120
Capsules

口碑质量

适应症:
吡非尼酮是一种吡啶酮,用于治疗特发性肺纤维化(IPF)。
推荐剂量:
1、每日三次,每次600mg,随食物服用。
2、开始治疗后,应在14天内将每日剂量增加至每天9粒胶
囊的全剂量。